Immune Dysregulation in Lyme Disease: Why Symptoms Persist

Immune dysregulation in Lyme disease may help explain why symptoms such as fatigue, pain, and cognitive changes can persist—even when tests are normal and initial treatment has been completed.

Many patients improve—but do not return fully to baseline. This page explains why.

Clinical Insight: Persistent symptoms in Lyme disease are often driven by dysregulated immune signaling rather than a single ongoing infection or abnormal lab result.

These patterns are commonly seen in delayed Lyme disease diagnosis, where early recognition is missed and symptoms evolve over time.

They are also closely linked to neuroinflammation and autonomic dysfunction, where immune signaling continues to influence nervous system function even after infection has been treated.

For the broader framework, see Persistent Lyme Disease Overview.

This page is part of the larger group of persistent Lyme disease mechanisms that connect immune, neurologic, and autonomic dysfunction.

Why symptoms can persist after infection

In most infections, the immune system activates, clears the threat, and then down-regulates. In some patients with Lyme disease, this resolution phase appears incomplete.

Instead of returning fully to baseline, immune signaling may remain altered. This can result in ongoing inflammatory messaging, heightened nervous system sensitivity, and impaired physiologic regulation—despite the absence of clear markers of active infection.

This reflects dysregulation—not simply overactivity or failure of the immune system.

What immune dysregulation means in Lyme disease

Immune dysregulation refers to impaired control of immune signaling rather than a single abnormal laboratory finding.

This may include:

Prolonged cytokine signaling
Difficulty terminating inflammatory responses
Shifts between immune activation and exhaustion
Altered communication between the immune and nervous systems

Importantly, these processes often occur below standard detection thresholds.

Clinical Insight: Patients may experience significant symptoms despite “normal” laboratory results because immune signaling abnormalities are not always captured by standard tests.

Neuroinflammation and immune dysregulation

The immune system and nervous system are tightly interconnected. Cytokines influence brain function, sleep, cognition, and sensory processing.

When immune signaling remains dysregulated, the brain may remain in a heightened or unstable state—commonly referred to as neuroinflammation.

Immune-autonomic interaction

Immune dysregulation also affects the autonomic nervous system, which regulates heart rate, blood pressure, digestion, and temperature control.

This helps explain overlap with autonomic dysfunction, including fatigue, orthostatic symptoms, and exercise intolerance.

Why symptoms fluctuate

A hallmark of immune dysregulation is variability. Symptoms often worsen during stress, poor sleep, infection, or exertion.

This reflects changing signaling—not disease progression.

Immune dysregulation and pain amplification

Persistent immune signaling can sensitize central pain pathways, lowering thresholds for pain perception and amplifying normal sensory input.

Immune dysregulation and gastrointestinal symptoms

The gastrointestinal system is highly sensitive to immune and autonomic signaling. Dysregulation can disrupt motility and coordination, leading to bloating, constipation, or discomfort.

How immune dysregulation relates to PTLDS

Post-Treatment Lyme Disease Syndrome (PTLDS) describes persistent symptoms after treatment.

Immune dysregulation provides a framework for understanding these symptoms without reducing them to a single cause.

Why this framework matters clinically

Recognizing immune dysregulation validates patient experience, explains multisystem symptoms, and shifts the focus toward physiologic regulation and recovery.